Takanori Hazama

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

Koji Abe, Masashi Aoki, Shoji Tsuji et al. · The Lancet Neurology · 2017 · 900 citations

Neurodegenerative Diseases, Amyotrophic Lateral Sclerosis, Neurological Disorder +6

Improvement of abnormal pyruvate metabolism and cardiac conduction defect with coenzyme Q _l0 in Kearns‐Sayre syndrome

Saburo Ogasahara, Shiro Yorifuji, Yoshiro Nishikawa et al. · Neurology · 1985 · 111 citations

Involvement of the central nervous system in myotonic dystrophy

Kazuo Abe, Harutoshi Fujimura, Keiko Toyooka et al. · Journal of the Neurological Sciences · 1994 · 75 citations

Neuromusculoskeletal Disorder, Neuroanatomy, Degenerative Disease +6

L-threo-3,4-dihydroxyphenylserine (L-DOPS) co-administered with entacapone improves freezing of gait in Parkinson’s disease

Kei Fukada, Takuyuki Endo, Masaru Yokoe et al. · Medical Hypotheses · 2012 · 51 citations

Medicine, Physiology, Parkinson ’ +6

The Motor Unit Number Index of Subclinical Abnormality in Amyotrophic Lateral Sclerosis

Kei Fukada, Toyoko Matsui, Mitsuru Furuta et al. · Journal of Clinical Neurophysiology · 2016 · 50 citations